Financhill
Back

Kairos Pharma Stock Predictions

Kairos Pharma Stock Forecast

  • Is Kairos Pharma Stock Undervalued?
    The current Kairos Pharma [KAPA] share price is $1.70. The Score for KAPA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • KAPA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Kairos Pharma Stock Go Up Next Year?

Data Unavailable

Kairos Pharma Stock Rating

Data Unavailable

Kairos Pharma Stock Price History

Is KAPA stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KAPA is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kairospharma.com

52-Week Data

52-Week High:
4.00
52-Week Low:
1.22

Prediction Charts

Market Cap:
21.83M
Price in USD:
1.70
Volume:
96.48K
Beta:
0.00

Technical Analysis

SMA50:
1.57
SMA100:
0.00
SMA200:
0.00
52-Wk Change:
0%

Stock Predictions

  • Is Kairos Pharma stock public?
    Yes, Kairos Pharma is a publicly traded company.
  • What is the Kairos Pharma stock quote today?
    The Kairos Pharma stock price is 1.70 USD today.
  • How to buy Kairos Pharma stock online?
    You can buy Kairos Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-7 1.31 1.37 1.39 1.30
Nov-8 1.40 1.34 1.40 1.31
Nov-11 1.38 1.36 1.38 1.30
Nov-12 1.40 2.05 2.21 1.37
Nov-13 2.55 2.21 2.75 1.69
Nov-14 2.12 2.06 2.33 1.88
Nov-15 2.06 1.55 2.07 1.55
Nov-18 1.59 1.71 1.86 1.59
Nov-19 1.56 1.47 1.62 1.40
Nov-20 1.45 1.46 1.53 1.41
Nov-21 1.46 1.50 1.55 1.37
Nov-22 1.55 1.60 1.87 1.41
Nov-25 1.70 1.70 1.73 1.52
Nov-26 1.67 1.70 1.73 1.56

Kairos Pharma Earnings

Data Unavailable

Kairos Pharma Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.13 per share.

* Kairos Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.